Charles River Laboratories: CFO Glenn Coleman bought 10 shares

What happened

• The filing shows Glenn Coleman, the chief financial officer, purchased 10 shares of Charles River Laboratories common stock at $297.43 per share on Sep 30, 2026, for a total of $2,974.
• The filing states the shares were acquired pursuant to the company's Employee Stock Purchase Plan and that the reporting person elected to participate during an open trading window prior to the quarterly purchase period.

Key details

• Transaction date and price: Sep 30, 2026; purchase at $297.43 per share.
• Total value: $2,974.
• Shares owned after the transaction: not reported in this filing.
• Footnote: shares acquired pursuant to the Employee Stock Purchase Plan; participation election made during an open trading window (footnote F1).
• Filing date: Oct 2, 2026.

Why it may matter

• This was a purchase under the company's employee purchase plan, not an option exercise or a gift.
• The filing does not show why the insider traded or why the company acted.